New York State Common Retirement Fund Buys 3,200 Shares of The Clorox Company (NYSE:CLX)

New York State Common Retirement Fund lifted its position in The Clorox Company (NYSE:CLX - Free Report) by 4.5% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 75,087 shares of the company's stock after purchasing an additional 3,200 shares during the quarter. New York State Common Retirement Fund owned 0.06% of Clorox worth $11,057,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. Redwood Park Advisors LLC bought a new stake in Clorox during the 4th quarter worth about $26,000. Millstone Evans Group LLC bought a new stake in Clorox during the 4th quarter worth about $31,000. Wood Tarver Financial Group LLC bought a new stake in Clorox during the 4th quarter worth about $31,000. GKV Capital Management Co. Inc. bought a new stake in Clorox during the 4th quarter worth about $32,000. Finally, Aster Capital Management DIFC Ltd bought a new stake in Clorox during the 4th quarter worth about $33,000. Institutional investors own 78.53% of the company's stock.

Insider Buying and Selling at Clorox

In other news, Director Pierre R. Breber bought 4,000 shares of the stock in a transaction dated Wednesday, May 7th. The shares were bought at an average cost of $136.57 per share, with a total value of $546,280.00. Following the completion of the transaction, the director directly owned 4,000 shares of the company's stock, valued at $546,280. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.57% of the stock is owned by insiders.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Morgan Stanley lowered their target price on Clorox from $165.00 to $150.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Barclays set a $119.00 target price on shares of Clorox and gave the company an "underweight" rating in a research note on Tuesday, July 15th. Evercore ISI set a $140.00 price target on Clorox and gave the company an "underperform" rating in a report on Tuesday, May 6th. Citigroup reissued a "neutral" rating and set a $135.00 target price (down previously from $140.00) on shares of Clorox in a report on Tuesday, July 15th. Finally, Wells Fargo & Company dropped their price target on Clorox from $142.00 to $135.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 9th. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $145.17.

Clorox Trading Down 0.8%

Shares of NYSE:CLX traded down $0.98 during midday trading on Friday, hitting $128.28. 1,662,271 shares of the stock were exchanged, compared to its average volume of 1,429,326. The stock has a market capitalization of $15.81 billion, a price-to-earnings ratio of 23.03, a P/E/G ratio of 3.37 and a beta of 0.51. The company has a debt-to-equity ratio of 13.07, a quick ratio of 0.44 and a current ratio of 0.74. The business's 50-day moving average price is $127.36 and its 200 day moving average price is $141.21. The Clorox Company has a 12 month low of $117.35 and a 12 month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. Clorox had a return on equity of 324.23% and a net margin of 9.89%. Clorox's revenue was down 8.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.71 earnings per share. Analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.